Skip to main content
SpringerLink
Log in

Nicht-infektiöse Nebenwirkungen gerinnungsaktiver Plasmapräparate

  • Conference paper
21. Hämophilie-Symposion

  • 27 Accesses

Zusammenfassung

Neben den infektiösen Nebenwirkungen dürfen nicht die nicht-infektiösen Risiken vergessen werden.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Hach-Wunderle V, Teixidor D, Zumpe P, Kühnl P, Scharrer I (1989) Anti-A in factor VIII concentrate: a cause of severe hemolysis in a patient with acquired factor VIII:C antibodies. Infusionstherapie 16:100–101

    PubMed  CAS  Google Scholar 

  2. Hilgartner M (1984) Antigen-antibody complexes in hemophilia. Scand J Hematol 33:335

    Article  Google Scholar 

  3. Levine PH (1986) Communication, Symp. Recent Advances in Hemophiliacs. Royal College of Physicians, Edinburgh, October 9 to 10

    Google Scholar 

  4. Blatt PM, Lundblad RL, Kingdon HS, McLean G, Roberts HR (1974) Thrombogenic materials in prothrombin complex concentrates. Ann Int Med 81:766

    PubMed  CAS  Google Scholar 

  5. Kasper CK (1975) Thromboembolic complications. Thromb Diath Hemorrh 33:640

    CAS  Google Scholar 

  6. Cederbaum AI, Blatt PM, Roberts H (1976) Intravascular coagulation with use of human prothrombin complex concentrates. Annals of Int Med 84:683–687

    CAS  Google Scholar 

  7. Schimpf K, Zimmermann K, Kömpf B (1976) DIC and postoperative wound bleeding under factor IX substitution therapy in a case of hemophilia B. Thromb Res 8:65–70

    Article  PubMed  CAS  Google Scholar 

  8. Davey RJ, Shashaty GG, Rath CE (1976) Acute coagulopathy following infusion of prothrombin complex concentrate. Am J Med 60:719

    Article  PubMed  CAS  Google Scholar 

  9. Aledort LM (1977) F.IX and thrombosis. Scand J of Hematology, Suppl No 30:40–42

    CAS  Google Scholar 

  10. Stenbjerg S, Jörgensen J (1977) Disseminated intravascular coagulation and infusion of factor-VIII-inhibitor bypassing activity. Lancet i:360

    Article  Google Scholar 

  11. Campbell EW, Neff S, Bowdler AJ (1978) Therapy with factor IX concentrate resulting in DIC and thromboembolic phenomena. Transfusion 18:94

    Article  PubMed  CAS  Google Scholar 

  12. Machin SJ, Miller BR (1978) Thrombosis and factor IX concentrate. Lancet i:1367

    Article  Google Scholar 

  13. Jones P (1978) Thrombosis and factor IX concentrates. Lancet: 156

    Google Scholar 

  14. Fukui H, Fujimura Y, Takahashi Y, Mikami S, Yoshioka A (1981) Laboratory evidence of DIC under FEIBA treatment of a hemophilic patient with intracranial bleeding and high titre factor VIII inhibitor. Thromb Res 22:177

    Article  PubMed  CAS  Google Scholar 

  15. Agrawal BL, Zelkowitz L, Hletku P (1981) Acute myocardial infarction in a young hemophiliac patient during therapy with factor IX concentrate and epsilon aminocaproic acid. J Pediatr 98:931

    Article  PubMed  CAS  Google Scholar 

  16. Kapser CK (1981) Management of inhibitors to factor VIII. Prog Hematol 12:143–163

    Google Scholar 

  17. Schimpf K, Zeltsch C, Zeltsch P (1982) Myokardial infarction complicating activated prothrombin complex concentrate substitution in a patient with hemophilia A. Lancet ii:1043

    Article  Google Scholar 

  18. Small M, Lowe GDO, Douglas JT, Forbes CD, Prentice CRM (1982) Factor IX thrombogenicity: in vivo effects on coagulation activation and a case report of disseminated intravascular coagulation. Thromb Hemostasis 48:76

    CAS  Google Scholar 

  19. Rodeghiero F, Menache D, Roberts HR (1982) Disseminated intravascular coagulation after infusion of FEIBA (factor VIII inhibitor bypassing activity) in a patient with acquired hemophilia. Thromb Hemostas 48:339

    CAS  Google Scholar 

  20. Gruppo RA, Bove KE, Donaldson VH (1983) Fatal myocardial necrosis associated with prothrombin complex concentrate therapy in hemophilia A. N Engl J Med 304: 242

    Google Scholar 

  21. Lusher JM, Eyster ME, Hilgartner MW (1984) Panel discussion on the treatment of patients with factor VIII inhibitors. Progr Clin Biol Res 150:323–335

    CAS  Google Scholar 

  22. Lusher JM (1985) Replacement therapy for congenital and acquired disorders of blood coagulation: Available products. In: Concepts in Transfusion Therapy, edited by G. Garray, 27–29. American Association of Blood Banks, Arlington, VA

    Google Scholar 

  23. Beard J, Savidge GF, Seghatchian MJ (1989) Nonviral complications of factor replacement in hemophilia and von Willebrand’s disease. In: Seghatchian MJ, Savidge GF (eds) Factor VIII — von Willebrand Factor. CRC Press Inc, Boca Raton, Florida, 269–280

    Google Scholar 

  24. Lusher, JM (1983) Management of hemophiliacs with inhibitors. In: Hilgartner M, Pochedly C (ed) Hemophilia in the child and adult. Ravon Press, Ltd, New York, 121–136

    Google Scholar 

  25. Chistolini A, Mazzucconi MG, Tirindelli MC, La Verde G, Ferrari A, Mandelli F (1990) Disseminated Intravascular coagulation and myocardial infarction in a hemophilia B patient during therapy with prothrombin complex concentrates. Acta Hematol 83:163–165

    Article  CAS  Google Scholar 

  26. Fulcher CA, Zimmerman TS (1989) Immunochemistry of factor VIII. In: Zimmerman TS, Ruggeri ZM (ed) Coagulation and bleeding disorders. Marcel Dekker, Inc New York, 47–58

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Frankfurt, Deutschland

    I. Scharrer

Authors
  1. I. Scharrer
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Husumer Straße 7, D-2000, Hamburg 20, Germany

    G. Landbeck

  2. Zentrum der Inneren Medizin, Abteilung für Angiologie, Universitätsklinikum, Theodor-Stern-Kai 7, D-6000, Frankfurt 70, Germany

    I. Scharrer

  3. Hämostaseologische Abteilung, Medizinische Klinik Innenstadt der Universität, Ziemssenstraße 1 a, D-8000, München 2, Germany

    W. Schramm

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Scharrer, I. (1991). Nicht-infektiöse Nebenwirkungen gerinnungsaktiver Plasmapräparate. In: Landbeck, G., Scharrer, I., Schramm, W. (eds) 21. Hämophilie-Symposion. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-76764-7_38

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-76764-7_38

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-54256-8

  • Online ISBN: 978-3-642-76764-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation